[1] Nakao A, Afrakhte M, Morén A, et al. Identification of Smad7, a TGF betainducible antagonist of TGFbeta signalling[J]. Nature, 1997, 389(6651):631-635. [2] Shen JL, Yan CH, Liu Y, et al. Studies of TGFbeta/Smads expression in lung cancer[J]. Yi Chuan Xue Bao, 2003, 30(7):681-686. [3] Li X, Yang XX, Hu NY, et al. A riskassociated single nucleotide polymorphism of SMAD7 is common to colorectal, gastric, and lung cancers in a Han Chinese population[J]. Mol Biol Rep, 2011, 38(8):5093-5097. [4] 郑荣寿, 张思维, 吴良有, 等. 中国肿瘤登记地区2008恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2012, 21(1):1-12. [5] Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2):69-90. [6] Jemal A, Thun MJ, Ries LA, et al. Annual report to the nation on the status of cancer, 1975—2005, featuring trends in lung cancer, tobacco use, and tobacco control[J]. J Natl Cancer Inst, 2008, 100(23):1672-1694. [7] 霍艳英, 胡迎春, 张开泰, 等. 非小细胞肺癌组织中Smad7表达谱的改变[J].中国药物与临床, 2005, 5(12):894-896. [8] 申景玲, 闰承慧, 刘艳, 等. TGFβ/Smads在肺癌中的表达研究[J]. 遗传学报, 2003, 30(7):681-686. |